Global Nanopore Sequencing Market Size was valued at USD 343.0 Mn in 2024 and is predicted to reach USD 1,949.5 Mn by 2034 at a 19.4% CAGR during the forecast period for 2025-2034.
Nanopore sequencing is a novel, scalable method that enables direct, real-time examination of lengthy DNA or RNA fragments. The technique operates by tracking how an electrical current changes when nucleic acids move through a protein nanopore. The resultant signal is often decoded to provide a particular sequence of DNA or RNA. The growing prevalence of genetic disorders, increasing demand for personalised medicine, and advancements in sequencing technology are the primary factors driving the market's rapid growth.
The market is growing, in large part, due to the potential uses of nanopore sequencing in various industries and its ability to deliver real-time data. Furthermore, the growth of biotechnology and pharmaceutical firms, population growth, improved healthcare facilities, and increasing public awareness of genetic illnesses all have a favourable impact on the nanopore sequencing industry.
Additionally, during the projection period, market participants would have more profitable opportunities due to the adoption of improved genetic treatments. However, worries about mistake rates are anticipated to hinder market expansion. During the forecast period, the nanopore sequencing market is expected to face challenges due to a shortage of skilled personnel.
Some of the Major Key Players in the Nanopore Sequencing Market are:
The nanopore sequencing market is segmented based on product, type of nucleotide sequenced, type of nanopore, application, and end-user. Based on product, the market is segmented into instruments and consumables. By type of nucleotide sequenced, the market is segmented into DNA and RNA. By type of nanopore, the market is segmented into solid state, biological, and hybrid. By application, the market is segmented into clinical research, human genetics, animal research, and others. By end-user, the market is segmented into clinical laboratories, biotechnological companies, academic & research institutes, and others.
The consumables segment is expected to hold a major global market share in 2024. The strong demand for kits and reagents is a primary driver of the dominance of consumables in the nanopore sequencing market. The increase in consumable usage is evident in various processes, including RNA and DNA sequencing. Additionally, these consumables are being used in hitherto undiscovered applications, which broadens their use and increases demand for them. The demand for dependable and effective consumables has increased in tandem with the development of nanopore sequencing technology. To ensure accurate and precise results in their genetic studies, scientists and researchers rely on these consumables.
The DNA segment led the nanopore sequencing market in 2024. The increasing clinical benefits of nanopore technologies in DNA sequencing, rising technological breakthroughs, and expanding strategic actions by prominent market players are the main drivers propelling the expansion of the DNA sector. Additionally, the growing clinical uses of nanopore sequencing technologies for DNA sequencing are anticipated to boost their use, which will boost the revenue of the studied segment throughout the projected period.
The North American nanopore sequencing market is expected to register the highest market share in revenue in the near future because of its highly developed healthcare system, substantial R&D expenditures, and the presence of important industrial players. Growing genetic problems and government support for genomics and tailored medicine drive market growth. In addition, Asia Pacific is projected to grow rapidly in the global Nanopore Sequencing market because cutting-edge genomics technologies are being used in both clinical and research settings. Collaborations and strong research institutes foster innovation and commercial expansion. In the Asia-Pacific area, nanopore sequencing is expanding quickly due to investments in biotechnology and research.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 343.0 Mn |
| Revenue Forecast In 2034 | USD 1,949.5 Mn |
| Growth Rate CAGR | CAGR of 19.4% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Type Of Nucleotide Sequenced, By Type Of Nanopore, By Application, End-User. and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | Bio-Rad Laboratories, Inc., Danaher Corporation, Pacific Biosciences, Oxford Nanopore Technologies Limited, QIAGEN, F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Thermo Fisher Scientific, Eurofins Scientific, Agilent Technologies, Inc., Myriad Genetics, Inc., and other prominent players. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Nanopore Sequencing Market-
Nanopore Sequencing Market- By Product
Nanopore Sequencing Market- By Type of Nucleotide Sequenced
Nanopore Sequencing Market- By Type of Nanopore
Nanopore Sequencing Market- By Application
Nanopore Sequencing Market- By End-User
Nanopore Sequencing Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanopore Sequencing Market Snapshot
Chapter 4. Global Nanopore Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Nanopore Sequencing Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Radiopharma Industry Trends
Chapter 5. Nanopore Sequencing Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Product:
5.2.1. Instruments
5.2.2. Consumables
Chapter 6. Nanopore Sequencing Market Segmentation 2: By Type of Nanopore, Estimates & Trend Analysis
6.1. Market Share by Type of Nanopore, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type of Nanopore:
6.2.1. Solid State
6.2.2. Biological
6.2.3. Hybrid
Chapter 7. Nanopore Sequencing Market Segmentation 3: By Type of Nucleotide Sequenced, Estimates & Trend Analysis
7.1. Market Share by Type of Nucleotide Sequenced 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type of Nucleotide Sequenced:
7.2.1. DNA
7.2.2. RNA
Chapter 8. Nanopore Sequencing Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share by Application, 2023 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Application:
8.2.1. Human Genetics
8.2.2. Clinical Research
8.2.3. Animal Research
8.2.4. Others
Chapter 9. Nanopore Sequencing Market Segmentation 5: By End-user, Estimates & Trend Analysis
9.1. Market Share by End-user, 2023 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following End-user:
9.2.1. Biotechnological Companies
9.2.2. Clinical Laboratories
9.2.3. Academic & Research Institutes
9.2.4. Others
Chapter 10. Nanopore Sequencing Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Nanopore Sequencing Market, Regional Snapshot 2023 & 2034
10.2. North America
10.2.1. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.2.3. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.2.4. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.2.5. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.6. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.3. Europe
10.3.1. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Denmark
10.3.1.2. Finland
10.3.1.3. Austria
10.3.1.4. France
10.3.1.5. Germany
10.3.1.6. Israel
10.3.1.7. Italy
10.3.1.8. Netherlands
10.3.1.9. Norway
10.3.1.10. Poland
10.3.2. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.3.3. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.3.4. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.3.5. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.6. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. Australia
10.4.1.2. China
10.4.1.3. India
10.4.1.4. Indonesia
10.4.1.5. Japan
10.4.1.6. Malaysia
10.4.1.7. Philippines
10.4.1.8. Singapore
10.4.1.9. South Korea
10.4.1.10. Taiwan
10.4.1.11. Thailand
10.4.1.12. Rest of APAC
10.4.2. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.4.3. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.4.4. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts By Type of Nucleotide Sequenced 2021-2034
10.4.5. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.6. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.5. Latin America
10.5.1. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Argentina
10.5.1.2. Brazil
10.5.1.3. Mexico
10.5.1.4. Rest of LATAM
10.5.2. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.5.3. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.5.4. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.5.5. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.6. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. Egypt
10.6.1.2. Israel
10.6.1.3. Nigeria
10.6.1.4. Saudi Arabia
10.6.1.5. Qatar
10.6.1.6. United Arab Emirates
10.6.1.7. Rest of MEA
10.6.2. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.6.3. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.6.4. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.6.5. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.6. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Pacific Biosciences
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Modeance
11.2.1.5. Geographical Presence
11.2.1.6. Recent Developments with Business Strategy
11.2.2. Oxford Nanopore Technologies Limited
11.2.3. QIAGEN
11.2.4. Eurofins Scientific
11.2.5. Agilent Technologies, Inc.
11.2.6. F. Hoffmann-La Roche Ltd.
11.2.7. Bio-Rad Laboratories, Inc.
11.2.8. Danaher Corporation, PerkinElmer Inc.
11.2.9. Thermo Fisher Scientific
11.2.10. Myriad Genetics, Inc.